OKYO (OKYO Pharma) Accounts Payable: $7.14 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OKYO OKYO Pharma Ltd OKYO
24 GF Score
Price $1.55
! 2 Warning Signs
View Full Analysis

What is OKYO Pharma Accounts Payable?

OKYO Pharma OKYO +6.16% 24 Accounts Payable is $7.14 Mil as of Mar. 2026. GuruFocus rates OKYO with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

OKYO Pharma's Accounts Payable for the quarter that ended in Mar. 2026 was $7.14 Mil.

OKYO Pharma's quarterly Accounts Payable declined from Mar. 2025 ($7.90 Mil) to Sep. 2025 ($7.11 Mil) but then increased from Sep. 2025 ($7.11 Mil) to Mar. 2026 ($7.14 Mil).

OKYO Pharma's annual Accounts Payable increased from Mar. 2024 ($6.13 Mil) to Mar. 2025 ($7.90 Mil) but then declined from Mar. 2025 ($7.90 Mil) to Mar. 2026 ($7.14 Mil).

OKYO Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Accounts Payable Chart

OKYO Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 2.32 6.13 7.90 7.14

OKYO Pharma Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.13 8.71 7.90 7.11 7.14
OKYO
24GF Score
OKYO Pharma Ltd OKYO
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $7.14 Mil mean?
OKYO Pharma (OKYO) has a Accounts Payable of $7.14 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on OKYO Pharma and its competitors.
Is OKYO Pharma's Accounts Payable too high?
OKYO Pharma's current Accounts Payable is $7.14 Mil. Overall, OKYO Pharma has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Accounts Payable compare to ENTX and HRTX?
OKYO Pharma's Accounts Payable of $7.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Accounts Payable is $7.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Accounts Payable of $7.14 Mil. The current Accounts Payable is $7.14 Mil. OKYO Pharma's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Accounts Payable is $7.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
24GF Score

Get the complete analysis for OKYO

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.55
Price